Table 3.
Comparison of predictive accuracy between the 8th TNM-GC and TNM-EC staging systems for AEG and type II patients
Training cohort (N = 705) | Concordance indices | |||
---|---|---|---|---|
C index | Bootstrap 95% CI | AIC | P value | |
TNM-GC system | 0.721 | 0.691–0.751 | 3174.5 | < 0.001* |
TNM-EC system | 0.690 | 0.659–0.721 | 3231.7 | |
Validation cohort (N = 705) | ||||
TNM-GC system | 0.721 | 0.692–0.750 | 3410.4 | < 0.001* |
TNM-EC system | 0.696 | 0.665–0.726 | 3458.2 | |
Training cohort (N = 436) for Siewert type II | ||||
TNM-GC system | 0.724 | 0.686–0.762 | 1811.1 | 0.005* |
TNM-EC system | 0.694 | 0.655–0.733 | 1840.8 | |
Validation cohort (N = 413) for Siewert type II | ||||
TNM-GC system | 0.723 | 0.684–0.762 | 1756.8 | < 0.001* |
TNM-EC system | 0.699 | 0.659–0.739 | 1785.2 |
TNM-GC AJCC 8th gastric cancer staging system, TNM-EC AJCC 8th esophageal cancer staging system, HR hazard ratio, 95% CI 95% confidence interval, AIC Akaike Information Criterion
*P < 0.05, statistical significance